首页> 美国卫生研究院文献>Springer Open Choice >Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter Post-Marketing Surveillance in Japan

【2h】

Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter Post-Marketing Surveillance in Japan

机译：Palivizumab预防免疫功能低下或唐氏综合症患儿呼吸道合胞病毒感染的预防：日本的多中心上市后监测

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveThe aim of this study was to assess the safety and effectiveness of palivizumab for the prevention of lower respiratory tract infection (LRI) caused by respiratory syncytial virus (RSV) in children with immunocompromised conditions or Down syndrome.

机译：目的本研究旨在评估帕利珠单抗预防免疫功能低下或唐氏综合症患儿由呼吸道合胞病毒（RSV）引起的下呼吸道感染（LRI）的安全性和有效性。

著录项

期刊名称 Springer Open Choice
作者
Tomoko Kashiwagi; Yukiko Okada; Ken Nomoto;
展开▼
作者单位

展开▼
年(卷),期 -1(20),1
年度 -1
页码 97–104
总页数 8
原文格式 PDF
正文语种
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in Japan [J] . Kashiwagi Tomoko, Okada Yukiko, Nomoto Ken Pediatric drugs . 2018,第1期

机译：Palivizumab预防免疫抑制病症或唐氏综合征儿童呼吸道合胞病毒感染：日本的多中心，营销后监测
2. Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in Japan (vol 20, pg 97, 2018) [J] . Kashiwagi Tomoko, Okada Yukiko, Nomoto Ken Pediatric drugs . 2018,第3期

机译：帕尔凡押灭绝预防免疫疗法病症或唐氏综合征儿童呼吸道同性恋病毒感染：日本多中心，营销后监测（Vol 20，PG 97,2018）
3. Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children Outcomes From the Canadian RSV Evaluation Study of Palivizumab Registry Over Twelve Seasons (2005-2017) [J] . Paes Bosco A., Saleem Mahwesh, Li Abby, The Pediatric infectious disease journal . 2020,第6期

机译：呼吸道合胞病毒预防免疫因素的免疫性儿童从十二季加拿大RSV评估研究中的呼吸劳动力评估研究（2005-2017）
4. Single Nucleotide Polymorphisms of CD14 Are Associated with the Development of Respiratory Syncytial Virus Bronchiolitis in Japanese Children [C] . Y. Inoue, N. Shimojo, E.J. Campos, Collegium Internationale Allergologicum . 2007

机译：CD14的单核苷酸多态性与日本儿童呼吸道合胞病毒支气管炎的发育有关
5. A Prospective Study of Respiratory Syncytial Virus Infection Among Children Attending Daycare. [D] . Chu, Helen Y. 2012

机译：参加日托的儿童中呼吸道合胞病毒感染的前瞻性研究。
6. Outcomes of Palivizumab Prophylaxis for Respiratory Syncytial Virus Infection in Preterm Children with Bronchopulmonary Dysplasia at a Single Hospital in Korea from 2005 to 2009 [O] . Seung Gu Chang, Moon Sung Park, Jae Eun Yu 2010

机译：2005年至2009年在韩国一家医院对早产儿支气管肺发育不良的呼吸道合胞病毒感染进行Palivizumab预防的结果
7. Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in Japan [O] . Tomoko Kashiwagi, Yukiko Okada, Ken Nomoto 2017

机译：帕尔凡押巴掌对免疫疗法病症或唐氏综合征的儿童呼吸道合胞病毒感染：日本的多中心，营销后监测

Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter Post-Marketing Surveillance in Japan

摘要

著录项

相似文献

相关主题

期刊订阅